GPX4 and obesity due to melanocortin 4 receptor deficiency: Carboplatin treatment was highly effective at reducing tumor growth regardless of GPX4 or obesity status (p < 0.01, each comparison), while GPX4 knockdown modestly reduced tumor progression in both nonobese and DIO mice.